รายงานสถานการณ์ วิเคราะห์รายงานสอบสวนวัณโรคดื้อยาหลายขนานชนิดรุนแรงมาก (XDR-TB) ของทีมสอบสวนโรคส่วนกลาง Joint Investigation Team หลังจากที่มีการประกาศเป็นโรคติดต่ออันตราย ภายใต้พระราชบัญญัติโรคติดต่อ 2558 และสังเคราะห์รูปแบบของการเขียนรายงานสอบสวนโรค XDR-
Keywords:
extensively drug–resistant tuberculosis (XDR-TB), investigation report guideline, and dangerous communicable diseaseAbstract
Background: Extensively drug–resistant tuberculosis (XDR-TB) was included as the dangerous communicable disease under the Communicable Diseases Act of 2015 and officers responsible for the disease investigation must write a report to the Department of Disease Control. However, the Act does not specify the guidelines for writing an XDR-TB investigation report. Developing a model for writing the report for those responsible is key to the accuracy and completeness of the report content. This in turn will better lead to the analysis of appropriate disease prevention and control policies.
Methods: The study model was divided into 4 main methods, namely a descriptive epidemiological study, literature review of the XDR-TB factors contributing of health changes, synthesis of XDR-TB investigation report writing model, and evaluate of the reports.
Results: Between January 2018 and December 2019, the central JIT collected 24 disease investigation reports. Based on the literature review, 41 variables were identified to be associated with XDR-TB. When combined with the principles of disease investigation report writing, these can then be divided into six components: background, investigation results, disease control activities that have been carried out, limitations in disease investigation, planning and suggestions, and summarizing the results of the XDR-TB investigation for the executive committee. From analysis of the disease investigation reports, as for the background component, it was found identified in majority of the reports. A variable specifying the notification time and specifying the time to go to the area to investigate the disease were found in only 17% and 8% of the reports, respectively. As for the prevention and control activities that have been carried out and recommendations, these were found in every report. However, problems and limitations in the investigation variable was only found in 25% of reports.
Conclusions: Guidelines for writing an investigation report on XDR-TB can be divided into six parts. Using this approach enables the JIT to analyze the data for risk factor identification and lead to timely and effective public health control and prevention measures. The JIT can also adjust for any additional or unnecessary factors depending on the circumstances and at their discretion.
References
ศูนย์กฎหมาย กรมควบคุมโรค. พระราชบัญญัติโรคติดต่อ พ.ศ. 2558. พิมพ์ครั้งที่ 6. กรุงเทพมหานคร: ศูนย์กฎหมาย กรม ควบคุมโรค; 2561.
กรมควบคุมโรค กระทรวงสาธารณสุข. ประกาศกระทรวง สาธารณสุข เรื่อง ชื่อและอาการสำคัญของโรคติดต่ออันตราย (ฉบับที่ 2). 2561 [เข้าถึงเมื่อ 5 มีนาคม 2564]. เข้าถึงได้จาก: https://ddc.moph.go.th/uploads/ckeditor/c74d97b01eae257e44aa9d5bade97baf/files/003_10gcd.PDF
Cates W. Epidemiology: Applying principles to clinical practice. Contemp Ob/Gyn 1982;20:147–61.
Taylor L, Knowelden J. Principles of Epidemiology. 2 ed. Boston: Little Brown & Co; 1964.
Centers for Disease Control and Prevention (CDC). Lesson 1: Introduction to Epidemiology. 2012 [cited 2021 March 5]. Available from: https://www.cdc.gov/csels/dsepd/ss1978/Lesson1/Section1.html#_ref2
European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2021–2019 data. Copenhagen: WHO Regional Office for Europe; 2021.
European Centre for Disease Prevention and Control (ECDC). European Union Standards for Tuberculosis Care 2017 update. Solna, Sweden: ECDC; 2017.
สำนักวัณโรค กรมควบคุมโรค. แนวทางปฏิบัติป้องกันควบคุม วัณโรคดื้อยาหลายขนานชนิดรุนแรงมาก ภายใต้พระราช บัญญัติโรคติดต่อ พ.ศ. 2558. กรุงเทพมหานคร: สำนักพิมพ์ อักษรกราฟฟิคแอนด์ดีไซน์; 2561. 9. สำนักระบาดวิทยา กรมควบคุมโรค. การเขียนรายงานการ สอบสวนทางระบาดวิทยา. 2550 [เข้าถึงเมื่อ 5 มีนาคม 2564]. เข้าถึงได้จาก: https://wwwnno.moph.go.th/epidnan /mypage/investigate/Investigation_report.pdf
European Centre for Disease Prevention and Control (ECDC). Writing an Outbreak Investigation Report. 2019 [cited 2021 March 5]. Available from: https://wiki.ecdc.europa.eu/fem/Pages/WritinganOutbreakInvestigationReport.aspx
Centers for Disease Control and Prevention (CDC). Investigating and Reporting. 2019 [cited 2021 March 5]. Available from: https://www.cdc.gov/healthywater/surveillance/investigating-reporting.html
Migliori GB, Richardson MD, Lange C. Of blind men and elephants: making sense of extensively drugresistant tuberculosis. Am J Respir Crit Care Med 2008; 178: 1000–1.
Centers for Disease Control and Prevention (CDC). CDC Tuberculosis Surveillance Data Training Report of Verified Case of Tuberculosis (RVCT) Instruction Manual. 2009 [cited 2021 March 5]. Available from: https://www.cdc.gov/tb/programs/rvct/InstructionMa nual.pdf
An der Heiden M, Hauer B, Fiebig L, Glaser-Paschke G, Stemmler M, Simon C, Rüsch-Gerdes S, Gilsdorf A, Haas W. Contact investigation after a fatal case of extensively drug-resistant tuberculosis (XDR-TB) in an aircraft, Germany, July 2013. Euro Surveill. 2017 Mar 23;22(12):30493. doi: 10.2807/1560-7917.ES.2017. 22.12.30493. PMID: 28367796; PMCID: PMC5388132.
Araújo-Filho J, Vasconcelos-Jr A, Sousa E, Silveira C, Ribeiro E, Kipnis A, et al. Extensively drug-resistant tuberculosis: a case report and literature review. Brazilian Journal of Infectious Diseases. 2008; 12(5): 447–52.
World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 2006.
Raviglione MC, Smith IM. XDR tuberculosis - implications for global public health. N Engl J Med 2007;356(7):656-9.
Ebrahim GJ. Drug resistance in tuberculosis. J Trop Pediatr. 2007;53:147-9.
Lawn SD, Wilkinson R. Extensively drug resistant tuberculosis. A serious wake-up call for global health. BMJ 2006;333:560-1.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Weekly Epidemiological Surveillance Report

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Responsibility and Copyright
1. Author Responsibility and Editorial Disagreement
The content and data in all articles published in WESR are the direct opinions and responsibility of the article authors, and the Journal's Editorial Board is not necessarily in agreement with, or jointly responsible for, them.
2. Copyright and Referencing
All articles, data, content, figures, etc., published in WESR are considered the copyright of the academic journal. If any individual or entity wishes to disseminate all or any part of the published material, appropriate citation of the article is required.

